DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Gavai AV. * et al. Bristol Myers Squibb Company, Princeton, USA
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design.
J. Med. Chem. 2021;
64: 14247-14265
DOI: 10.1021/acs.jmedchem.1c00625.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.